» Articles » PMID: 32641876

Curcumin: a Wonder Drug As a Preventive Measure for COVID19 Management

Overview
Specialty Biochemistry
Date 2020 Jul 10
PMID 32641876
Citations 33
Authors
Affiliations
Soon will be listed here.
Citing Articles

Evaluation of curcumin-loaded chitosan nanoparticles for wound healing activity.

Kumbhar S, Khairate R, Bhatia M, Choudhari P, Gaikwad V ADMET DMPK. 2023; 11(4):601-613.

PMID: 37937244 PMC: 10626514. DOI: 10.5599/admet.1897.


The Use of D-Optimal Mixture Design in Optimizing Formulation of a Nutraceutical Hard Candy.

Souiy Z, Amri Z, Sharif H, Souiy A, Cheraief I, Hamden K Int J Food Sci. 2023; 2023:7510452.

PMID: 36968159 PMC: 10033211. DOI: 10.1155/2023/7510452.


Comparative docking studies of drugs and phytocompounds for emerging variants of SARS-CoV-2.

Chugh A, Sehgal I, Khurana N, Verma K, Rolta R, Vats P 3 Biotech. 2023; 13(1):36.

PMID: 36619821 PMC: 9815891. DOI: 10.1007/s13205-022-03450-6.


Role of Dantabija, Haridra, and Zingiber (DHZ) combination to restore health and immunity in mild to moderate COVID-19 patients.

Kumar Y, Agarwal M, Bhushan D, Pati B, Jha K, Kumari A J Family Med Prim Care. 2023; 11(10):6067-6073.

PMID: 36618209 PMC: 9810921. DOI: 10.4103/jfmpc.jfmpc_453_22.


Strategies for Improving Bioavailability, Bioactivity, and Physical-Chemical Behavior of Curcumin.

Racz L, Racz C, Pop L, Tomoaia G, Mocanu A, Barbu I Molecules. 2022; 27(20).

PMID: 36296447 PMC: 9608994. DOI: 10.3390/molecules27206854.


References
1.
Li H, Yang M, Li Z, Meng Z . Curcumin inhibits angiotensin II-induced inflammation and proliferation of rat vascular smooth muscle cells by elevating PPAR-γ activity and reducing oxidative stress. Int J Mol Med. 2017; 39(5):1307-1316. DOI: 10.3892/ijmm.2017.2924. View

2.
Praditya D, Kirchhoff L, Bruning J, Rachmawati H, Steinmann J, Steinmann E . Anti-infective Properties of the Golden Spice Curcumin. Front Microbiol. 2019; 10:912. PMC: 6509173. DOI: 10.3389/fmicb.2019.00912. View

3.
Keidar S, Kaplan M, Gamliel-Lazarovich A . ACE2 of the heart: From angiotensin I to angiotensin (1-7). Cardiovasc Res. 2006; 73(3):463-9. DOI: 10.1016/j.cardiores.2006.09.006. View

4.
Jean S, Lee P, Hsueh P . Treatment options for COVID-19: The reality and challenges. J Microbiol Immunol Infect. 2020; 53(3):436-443. PMC: 7129535. DOI: 10.1016/j.jmii.2020.03.034. View

5.
Das S, Sarmah S, Lyndem S, Singha Roy A . An investigation into the identification of potential inhibitors of SARS-CoV-2 main protease using molecular docking study. J Biomol Struct Dyn. 2020; 39(9):3347-3357. PMC: 7232884. DOI: 10.1080/07391102.2020.1763201. View